These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31714150)

  • 1. "I Just Feel Like I Always Did": Inotropic Dependency at End of Life.
    Latimer A; Pope ND; McFarlin JM
    Am J Hosp Palliat Care; 2020 Jul; 37(7):497-502. PubMed ID: 31714150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
    López-Candales AL; Carron C; Schwartz J
    Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home Inotropes and Other Palliative Care.
    Ginwalla M
    Heart Fail Clin; 2016 Jul; 12(3):437-48. PubMed ID: 27371519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Intravenous Inotropic Support for Advanced Heart Failure: Palliative Considerations.
    McPherson A; Nguyen C; Groninger H; Anderson KM; Henderson P; Rao A
    J Pain Palliat Care Pharmacother; 2022 Mar; 36(1):59-67. PubMed ID: 35319327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology.
    Gustafsson F; Damman K; Nalbantgil S; Van Laake LW; Tops LF; Thum T; Adamopoulos S; Bonios M; Coats AJ; Crespo-Leiro MG; Mehra MR; Filippatos G; Hill L; Metra M; Jankowska E; de Jonge N; Kaye D; Masetti M; Parissis J; Milicic D; Seferovic P; Rosano G; Ben Gal T
    Eur J Heart Fail; 2023 Apr; 25(4):457-468. PubMed ID: 36847113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced heart failure patients supported with ambulatory inotropic therapy: What defines success of therapy?
    Grubb CS; Truby LK; Topkara VK; Bohnen MS; Yuzefpolskaya M; DeFilippis EM; Kleet A; Nakagawa S; Haythe JH; Axsom K; Colombo P; Takeda K; Uriel N; Sayer G; Garan H; Naka Y; Farr M
    Am Heart J; 2021 Sep; 239():11-18. PubMed ID: 33984317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of positive inotropes in end-of-life heart failure care.
    Nauman DJ; Hershberger RE
    Curr Heart Fail Rep; 2007 Sep; 4(3):158-63. PubMed ID: 17883992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous continuous home inotropic therapy in advanced heart failure: Insights from an observational retrospective study.
    Gentile P; Masciocco G; Palazzini M; Tedeschi A; Ruzzenenti G; Conti N; D'Angelo L; Foti G; Perna E; Verde A; Ammirati E; Sinagra G; Oliva F; Garascia A
    Eur J Intern Med; 2023 Oct; 116():65-71. PubMed ID: 37393183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inotropic therapy for heart failure: an evidence-based approach.
    Felker GM; O'Connor CM
    Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home Therapies in Advanced Heart Failure: Inotropes and Diuretics.
    Graffagnino JP; Avant LC; Calkins BC; Swetz KM
    Curr Heart Fail Rep; 2020 Oct; 17(5):314-323. PubMed ID: 32830304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Inotrope Therapy in Hospice Care: A Case Series.
    Patel K; D'Souza A; Groninger H
    Am J Hosp Palliat Care; 2019 Jul; 36(7):660-663. PubMed ID: 30630349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dilemma of late-stage heart failure. Rationale for chronic parenteral inotropic support.
    Mehra MR; Uber PA
    Cardiol Clin; 2001 Nov; 19(4):627-36. PubMed ID: 11715183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Intravenous Inotropic Support as Palliative Therapy and Bridge Therapy for Patients With Advanced Heart Failure: A Single-Center Experience.
    Rao A; Anderson KM; Mohammed S; Hofmeyer M; Gholami SS; Sheikh FH; Rodrigo ME; Crowell NA; Javed H; Gupta S; Hajouli S; Stewart DE; Hamad A; Najjar SS; Groninger H
    J Card Fail; 2021 Sep; 27(9):974-980. PubMed ID: 34153459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Cardiac Inotropes in Patients With End-Stage Heart Failure: An Evolving Experience.
    Malotte K; Saguros A; Groninger H
    J Pain Symptom Manage; 2018 Jan; 55(1):159-163. PubMed ID: 29030210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [End-stage heart failure: quantity or quality of life?].
    Delahaye F; Mercusot A; Carra L; Gouton M
    Arch Mal Coeur Vaiss; 2005 Mar; 98(3):186-91. PubMed ID: 15816320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative Inotrope Therapy: A Narrative Review.
    Chuzi S; Allen LA; Dunlay SM; Warraich HJ
    JAMA Cardiol; 2019 Aug; 4(8):815-822. PubMed ID: 31268467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-of-life options for patients with advanced heart failure.
    Goldfinger JZ; Adler ED
    Curr Heart Fail Rep; 2010 Sep; 7(3):140-7. PubMed ID: 20585999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Inotropic Agents in Treatment of Systolic Heart Failure.
    Tariq S; Aronow WS
    Int J Mol Sci; 2015 Dec; 16(12):29060-8. PubMed ID: 26690127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational use of inotropic therapy in heart failure.
    Felker GM; O'Connor CM
    Curr Cardiol Rep; 2001 Mar; 3(2):108-13. PubMed ID: 11177666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.